Literature DB >> 7839809

Which are the major determinants for outcome in aneurysmal subarachnoid hemorrhage? A prospective total management study from a strictly unselected series.

H Säveland1, L Brandt.   

Abstract

In this prospective study we report the outcome for all patients with a verified aneurysmal SAH managed at the Department of Neurosurgery at the University Hospital in Lund, Sweden during the four-year span from June 1, 1989 to May 31, 1993. A total of 275 patients were admitted during the study period. The vast majority of patients (196 individuals, i.e. 71%) was admitted within 24 h after the bleed. Mean age was 54.3 years and the female/male ratio 1.8/1. Nimodipine was administered in 231 (84%) of the 275 patients. We clipped the ruptured aneurysm in 199 patients. At follow-up 3 months after the bleed 161 patients were classified as having made a good neurological recovery (59%). The morbidity was 20% and 59 patients (21%) had died. The overwhelming cause for morbidity and mortality was damage from the initial bleed (62 patients, 23%). Notably, considering morbidity and mortality, delayed ischemia was less frequent than both surgical complications and rebleeding, respectively. Of the 275 patients, 13 (5%) patients made an unfavorable outcome due to delayed ischemic deterioration. There was a strict correlation between the initial clinical condition and final outcome. Of 51 grade V patients, only 2 made a good recovery. There was also a strict correlation between the amount of extravasated blood and outcome. There was no difference in clinical outcome between patients with arterial hypertension versus normotensive individuals. The mortality rate was worse for posterior circulation aneurysms.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7839809     DOI: 10.1111/j.1600-0404.1994.tb02715.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

1.  Staged endovascular management of a ruptured intracranial aneurysm.

Authors:  P Morris; M Bednar; C Gross
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

2.  Risk-benefit analysis of the treatment of unruptured intracranial aneurysms.

Authors:  R R Vindlacheruvu; A D Mendelow; P Mitchell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-02       Impact factor: 10.154

3.  Aneurysmal subarachnoid haemorrhage: outcomes of early rehabilitation after surgical repair of ruptured intracranial aneurysms.

Authors:  B M Saciri; N Kos
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

4.  Predictors for cognitive impairment one year after surgery for aneurysmal subarachnoid hemorrhage.

Authors:  M Orbo; K Waterloo; A Egge; J Isaksen; T Ingebrigtsen; B Romner
Journal:  J Neurol       Date:  2008-10-07       Impact factor: 4.849

5.  A multiparameter panel method for outcome prediction following aneurysmal subarachnoid hemorrhage.

Authors:  Natacha Turck; Laszlo Vutskits; Paola Sanchez-Pena; Xavier Robin; Alexandre Hainard; Marianne Gex-Fabry; Catherine Fouda; Hadiji Bassem; Markus Mueller; Frédérique Lisacek; Louis Puybasset; Jean-Charles Sanchez
Journal:  Intensive Care Med       Date:  2009-09-17       Impact factor: 17.440

6.  Acute management of poor condition subarachnoid hemorrhage patients.

Authors:  Archavlis Eleftherios; Mario Nazareno Carvi y Nievas
Journal:  Vasc Health Risk Manag       Date:  2007

7.  Early and persistent high level of PS 100β is associated with increased poor neurological outcome in patients with SAH: is there a PS 100β threshold for SAH prognosis?

Authors:  Hervé Quintard; Sébastien Leduc; Patricia Ferrari; Isabelle Petit; Carole Ichai
Journal:  Crit Care       Date:  2016-02-03       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.